As of 2024-12-11, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (441.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -183048.4%.
The range of the Relative Valuation is (448.94) - (464.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 25.0x | 18.4x |
| Forward P/E multiples | 19.4x - 20.1x | 19.8x |
| Fair Price | (448.94) - (464.64) | (441.09) |
| Upside | -186305.1% - -192818.4% | -183048.4% |
| Date | P/E |